We are live on ! Find out more

3,820 hedge funds and large institutions have $253B invested in Merck in 2026 Q2 according to their latest regulatory filings, with 209 funds opening new positions, 1,628 increasing their positions, 1,491 reducing their positions, and 117 closing their positions.

New
Increased
Maintained
Reduced
Closed

79% more first-time investments, than exits

New positions opened: 209 | Existing positions closed: 117

8% more capital invested

Capital invested by funds: $234B → $253B (+$19.7B)

1.83% more ownership

Funds ownership: 78.1%79.93% (+1.8%)

9% more repeat investments, than reductions

Existing positions increased: 1,628 | Existing positions reduced: 1,491

1% more funds holding

Funds holding: 3,7963,820 (+24)

0% less call options, than puts

Call options by funds: $3.18B | Put options by funds: $3.18B

12% less funds holding in top 10

Funds holding in top 10: 8978 (-11)

Holders
3,820
Holders Change
+24
Holders Change %
+0.63%
% of All Funds
46.14%
Holding in Top 10
78
Holding in Top 10 Change
-11
Holding in Top 10 Change %
-12.36%
% of All Funds
0.94%
New
209
Increased
1,628
Reduced
1,491
Closed
117
Calls
$3.18B
Puts
$3.18B
Net Calls
-$2.75M
Net Calls Change
-$654M
Name Holding Trade Value Shares
Change
Change in
Stake
PCS
1326
Personal CFO Solutions
New Jersey
$3.17M +$71K +607 +3%
PHS
1327
Pekin Hardy Strauss
Illinois
$3.16M -$9.83K -84 -0.3%
UF
1328
Univest Financial
Pennsylvania
$3.16M -$50.2K -429 -2%
MTC
1329
Matrix Trust Company
Colorado
$3.16M -$171K -1,458 -6%
WG
1330
Wellington Group
Indiana
$3.16M
AA
1331
Argent Advisors
Louisiana
$3.15M -$24.7K -211 -0.9%
TIM
1332
Thompson Investment Management
Wisconsin
$3.14M +$1.99K +17 +0.1%
FG
1333
Fiduciary Group
Georgia
$3.14M +$45.1K +385 +2%
MSA
1334
Marino Stram & Associates
Massachusetts
$3.14M -$64.7K -553 -2%
3IP
1335
3Chopt Investment Partners
Virginia
$3.13M +$235K +2,004 +9%
AG
1336
AlTi Global
New York
$3.13M +$78.9K +674 +3%
NG
1337
Northstar Group
New York
$3.11M -$5.15K -44 -0.2%
NW
1338
Naviter Wealth
Arkansas
$3.1M +$278K +2,375 +11%
OIA
1339
Oakmont Investment Advisors
Pennsylvania
$3.1M +$11.8K +101 +0.4%
CV
1340
Counterweight Ventures
North Carolina
$3.09M -$118K -1,005 -4%
HKIM
1341
Hayek Kallen Investment Management
Alabama
$3.09M +$40.6K +347 +1%
MA
1342
MCF Advisors
Kentucky
$3.08M -$50K -427 -2%
CPC
1343
CFC Planning Company
Indiana
$3.08M -$131K -1,121 -4%
SMC
1344
Smith, Moore & Co
Missouri
$3.08M -$234K -1,997 -8%
CAAS
1345
Capital Asset Advisory Services
Michigan
$3.08M +$201K +1,715 +8%
CWG
1346
Cornerstone Wealth Group
North Carolina
$3.08M +$66K +564 +2%
AFP
1347
Ausdal Financial Partners
Iowa
$3.08M +$297K +2,541 +12%
HAC
1348
Harbor Advisory Corp
New Hampshire
$3.07M
NFG
1349
Nations Financial Group
Iowa
$3.07M +$55.9K +478 +2%
WWA
1350
WCG Wealth Advisors
Nevada
$3.07M +$16.9K +144 +0.6%

MRK Hedge Fund Activity: Q2 2026 in Review

3,820 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q2 2026, worth a combined $253B — up 8.4% from $234B a quarter earlier.

Buyers outnumbered sellers: 209 funds opened new MRK positions and 117 closed out — a net gain of 92 holders — while 1,628 added to existing stakes and 1,491 trimmed.

The largest buyer was Capital International Investors, adding an estimated $1.7B. The largest seller was JP Morgan Chase, cutting an estimated $1.06B.

  • 3,820 institutional investors held Merck (MRK) as of Q2 2026, up from 3,796 in Q1 2026.
  • Funds reported $253B of Merck stock for Q2 2026, up 8.4% quarter-over-quarter.
  • 209 funds opened new Merck positions in Q2 2026 and 117 closed out, a net change of +92 holders.
  • The largest Merck buyer in Q2 2026 was Capital International Investors, an estimated $1.7B added.
  • The largest Merck seller in Q2 2026 was JP Morgan Chase, an estimated $1.06B sold.

Based on aggregated 13F filings for Q2 2026.